Bcl-xL expression in vivo in rheumatoid synovium

  • Sandra Busteed
  • , M. W. Bennett
  • , C. Molloy
  • , A. Houston
  • , M. A. Stone
  • , F. Shanahan
  • , M. G. Molloy
  • , J. O'Connell

Research output: Contribution to journalArticlepeer-review

Abstract

To examine the expression of the apoptosis regulatory protein, Bcl-xL, in the synovium of patients with rheumatoid arthritis (RA) and osteoarthritis (OA). Immunohistochemistry for Bcl-xL was carried out on synovial samples from patients with RA and OA. Reverse transcriptase polymerase chain reaction (RT-PCR) and Western blot analysis were performed to qualitatively examine the expression of Bcl-xL. Bcl-xL expression was detected in the lining, endothelium and inflammatory cells of both RA (n=20) and OA (n=10) samples. However, there was significantly more expression in the lining of RA synovium compared to OA (77 vs 61%, p<0.05). Many of the positive cells in the RA subsynovium were noted to be plasma cells. There was a significant correlation between Bcl-xL expression and the number of inflammatory cells in the subsynovium of RA and OA patients (rs=0.376, p<0.05, n=30). Age and disease duration did not correlate with Bcl-xL expression in rheumatoid patients. Bcl-xL may play a role in the extended survival of synoviocytes and inflammatory cells in rheumatoid synovium.

Original languageEnglish
Pages (from-to)789-793
Number of pages5
JournalClinical Rheumatology
Volume25
Issue number6
DOIs
Publication statusPublished - Nov 2006

Keywords

  • Apoptosis
  • Rheumatoid arthritis
  • Synovium

Fingerprint

Dive into the research topics of 'Bcl-xL expression in vivo in rheumatoid synovium'. Together they form a unique fingerprint.

Cite this